FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W103465954> ?p ?o ?g. }

• W103465954 abstract "Background: Circulating bone marrow-derived stem cells are capable of homing to sites of myocardial infarction and endothelial disruption, thereby restoring myocardial function and microvascular integrity after acute myocardial infarction. We compared the effects of atorvastatin 10 mg versus 40 mg in follow-up clinical events and in restoring coronary flow reserve (CFR) during the 8 months follow-up in patients with acute myocardial infarction. Methods: CFR, which is reflective of the integrity of coronary microvasculature, was measured by using intracoronary Doppler wire in 102 consecutive patients with acute myocardial infarction 5 days after the successful primary coronary intervention with sirolimus-eluting stents. Stented patients were randomly assigned to either atorvastatin 10 mg (ATOR10, n=52) or atorvastatin 40 mg (ATOR40, n=50). All patients received aspirin and clopidogrel. Clinical events such as death, myocardial infarction, and target lesion revascularization (TLR) were compared during the 8-month follow-up. Results: CFR increased significantly in both groups during the 8 months follow-up (1.9 ± 0.6 at baseline vs. 2.6 ± 0.7 at follow-up in the ATOR10, p<0.05; 1.9 ± 0.7 at baseline vs. 2.9 ± 0.8 at follow-up in the ATOR40, p<0.05). The changes from baseline in CFR was greater in the ATOR40 Group compared with the ATOR10 Group (1.0 ± 0.8 vs. 0.7 ± 0.6, p<0.05, respectively). The numbers of CD34+ and CXCR4+ cells were significantly greater in the ATOR40 Group compared with the ATOR10 Group (13 ± 10 vs. 6 ± 6, p<0.05, respectively for CD34 cells and 15 ± 14 vs. 10 ± 9, p<0.05, respectively for CXCR4+ cells per 1uL). Clinical events such as death (0 patient in the ATOR10 vs. 2 patients in the ATOR40, p=0.247), myocardial infarction (2 patients in the ATOR10 vs. 1 patient in the ATOR40, p=0.557), and TLR (2 patients in the ATOR10 vs. 2 patients in the ATOR40, p=0.692) demonstrated no significant differences during the follow-up. Conclusion: The increases from baseline in CFR, CD34+ cells and CXCR4+ cells were significantly greater in the ATOR40 Group compared with the ATOR10 Group. However, the improvement in left ventricular systolic function and the rate of clinical events revealed no significant differences between the 2 groups." @default.
• W103465954 created "2016-06-24" @default.
• W103465954 creator A5011713829 @default.
• W103465954 creator A5012930130 @default.
• W103465954 creator A5037704369 @default.
• W103465954 creator A5040153631 @default.
• W103465954 creator A5061549657 @default.
• W103465954 creator A5067351808 @default.
• W103465954 creator A5070378270 @default.
• W103465954 creator A5079795742 @default.
• W103465954 creator A5091627289 @default.
• W103465954 date "2007-10-16" @default.
• W103465954 modified "2023-09-25" @default.
• W103465954 title "Abstract 3339: Effects of Atorvastatin 10 mg versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Clinical Events in Patients with Acute Myocardial Infarction" @default.
• W103465954 doi "https://doi.org/10.1161/circ.116.suppl_16.ii_752-b" @default.
• W103465954 hasPublicationYear "2007" @default.
• W103465954 type Work @default.
• W103465954 sameAs 103465954 @default.
• W103465954 citedByCount "0" @default.
• W103465954 crossrefType "journal-article" @default.
• W103465954 hasAuthorship W103465954A5011713829 @default.
• W103465954 hasAuthorship W103465954A5012930130 @default.
• W103465954 hasAuthorship W103465954A5037704369 @default.
• W103465954 hasAuthorship W103465954A5040153631 @default.
• W103465954 hasAuthorship W103465954A5061549657 @default.
• W103465954 hasAuthorship W103465954A5067351808 @default.
• W103465954 hasAuthorship W103465954A5070378270 @default.
• W103465954 hasAuthorship W103465954A5079795742 @default.
• W103465954 hasAuthorship W103465954A5091627289 @default.
• W103465954 hasConcept C126322002 @default.
• W103465954 hasConcept C164705383 @default.
• W103465954 hasConcept C2777482532 @default.
• W103465954 hasConcept C2777849778 @default.
• W103465954 hasConcept C2777995511 @default.
• W103465954 hasConcept C2778213512 @default.
• W103465954 hasConcept C2778707443 @default.
• W103465954 hasConcept C2779464278 @default.
• W103465954 hasConcept C2780400711 @default.
• W103465954 hasConcept C500558357 @default.
• W103465954 hasConcept C71924100 @default.
• W103465954 hasConceptScore W103465954C126322002 @default.
• W103465954 hasConceptScore W103465954C164705383 @default.
• W103465954 hasConceptScore W103465954C2777482532 @default.
• W103465954 hasConceptScore W103465954C2777849778 @default.
• W103465954 hasConceptScore W103465954C2777995511 @default.
• W103465954 hasConceptScore W103465954C2778213512 @default.
• W103465954 hasConceptScore W103465954C2778707443 @default.
• W103465954 hasConceptScore W103465954C2779464278 @default.
• W103465954 hasConceptScore W103465954C2780400711 @default.
• W103465954 hasConceptScore W103465954C500558357 @default.
• W103465954 hasConceptScore W103465954C71924100 @default.
• W103465954 hasIssue "suppl_16" @default.
• W103465954 hasLocation W1034659541 @default.
• W103465954 hasOpenAccess W103465954 @default.
• W103465954 hasPrimaryLocation W1034659541 @default.
• W103465954 hasRelatedWork W1983829728 @default.
• W103465954 hasRelatedWork W2011576613 @default.
• W103465954 hasRelatedWork W2127687375 @default.
• W103465954 hasRelatedWork W2236042039 @default.
• W103465954 hasRelatedWork W2353581447 @default.
• W103465954 hasRelatedWork W2776256109 @default.
• W103465954 hasRelatedWork W3141478988 @default.
• W103465954 hasRelatedWork W4294307644 @default.
• W103465954 hasRelatedWork W4309844009 @default.
• W103465954 hasRelatedWork W2527719101 @default.
• W103465954 hasVolume "116" @default.
• W103465954 isParatext "false" @default.
• W103465954 isRetracted "false" @default.
• W103465954 magId "103465954" @default.
• W103465954 workType "article" @default.